🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

TAVR UNLOAD just presented at TCT. First RCT in moderate AS and HFrEF. The trial did not meet the primary endpoint at last FU but early TAVR was superior to clinical surveillance at 1 year.

Very proud and honored to be in 2024 for the seventh consecutive year among the most influential scientists in clinical medicine. I am so grateful to my wonderful team IUCPQ-ULaval

Dear followers I will not post anymore on X. I encourage you to follow me on BlueSky or LinkedIn. Thank you for your support. Chers followers, à partir d’aujourd’hui je n’utiliserai plus la plateforme X. Je vous encourage à me suivre sur BlueSky et LinkedIn. Merci.

The Heart Valve Society and Its Journal Finally Meet – The Future Is Bright. In the first inaugural issue of the #JournaloftheHeartValveSociety (journals.sagepub.com/toc/HVS/current), Dr Ismail El-Hamamsy, MD, PhD, the president of the #HVS highlights the rising global burden of heart valve disease and the

✨Just published in the first issue of the #JHVS: 3-year results of the AVIATOR REGISTRY🫀 including 2,206 patients with aortic valve regurgitation who underwent aortic valve intervention. Surgical repair was associated with better survival than valve replacement. AR ≥ grade 2

Delve into the intricate dynamics of the extracellular matrix in the aortic valve, particularly on its role in health and disease such as calcific aortic stenosis (CAS), innovative biomimetic platforms that mimic CAS fibrosis, and insights for developing therapeutic strategies.

Just published in the first issue of #JHVS: Women with small aortic annulus are less likely to experience prosthesis-patient mismatch (PPM) after TAVR compared to SAVR. Read more here👇 journals.sagepub.com/doi/full/10.11… Link to the editorial👇 journals.sagepub.com/doi/full/10.11…

Approximately 9% of the patients with severe AS also had PAD. Notably, these patients faced a significantly higher risk of mortality, with a 1.6-fold increase compared to those without PAD. The presence of both PAD and CAD exacerbated the risk, leading to a 1.92-fold increase in

Just published in the first issue of the #JHVS: Cardiovascular magnetic resonance as a non-invasive tool to assess myocardial fibrosis in AS. This elegant review underscores the prognostic value of these imaging markers such as late gadolinium enhancement (LGE) and T1-mapping and

Just published in the first issue of JHVS: Focus on the complex interplay between cardiac amyloidosis and aortic stenosis. Importance of heightened clinical awareness, early diagnosis through advanced imaging, and tailored therapeutic strategies to improve patient outcomes. Read

Just published in the first issue of #JHVS: Intersection of AS and chronic kidney disease (CKD): a call to action for clinicians to adopt a comprehensive, patient-centered approach in managing AS in CKD, advocating for guidelines that address this complex clinical interplay. Read

The role of multimodality imaging in assessing AS and the challenges and advancements in diagnosing AS. The review emphasizes the importance of less flow-dependent modalities in evaluating AS severity and underscores the evolving landscape of AS assessment, highlighting the

Just published in the first issue of #JHVS: The Ross procedure in adults, a surgical technique that has gained renewed interest in recent years. This review highlights the evolution of surgical techniques to enhance the durability of the Ross procedure, addressing potential

The Aortic Valve Research Network Investigators presents the Heart Valve Society Aortic Valve Database, which is a pivotal resource in advancing our understanding and treatment of aortic valve disease. The #HVS Aortic Valve Database is a comprehensive, multicenter platform

Challenging the recently introduced concept of extra-valvular cardiac damage staging in #HVD by introducing the importance of considering the entire spectrum of cardiac damage when deciding on interventions, as these procedures, although often improving symptoms, may not always

🥊Just published in the first issue of #JHVS: Which is the best modality to assess bioprosthetic valve hemodynamic function and adjudicate valve dysfunction following transcatheter aortic valve replacement: Doppler echocardiography or invasive assessment by cardiac

Just published in the first issue of #JHVS: Cahalane et al. present the mission of the recently launched young investigator board of the Heart Valve Society, an initiative that not only provides a platform for networking and collaboration but also offers resources for career

Just published in this first issue of the #JHVS: The first ICHOM standards for the reporting of patient-centered outcomes in heart valve disease. The ICHOM Set of Patient-Centered Outcome Measures for Heart Valve Disease results from hard work by a group of leading healthcare

Just published in the first issue of #JHVS: In-memoriam🕊️article to underline the outstanding career and contribution of Pr Alain Cribier, who passed away earlier this year. Pr Alain Cribier was a pioneer and a giant in the advancement of the treatment of #HVD. He and his team at

Such an important editorial - A Must Read: Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis-The Time Has Come pubmed.ncbi.nlm.nih.gov/39937467/